In vitro antimicrobial activity of the filtrate crude extract produced by aspergillus Niger
Introduction: Aspergillus niger represents one of the fungi that can produce the secondary metabolites, including antimicrobial agents, industrial and biotechnological products. Methodology: A. niger was tested against Candida albicans on the same petri dish of potato dextrose agar at room temperatu...
Gespeichert in:
Veröffentlicht in: | مجلة علوم ذي قار 2019-06, Vol.7 (1), p.66-71 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction: Aspergillus niger represents one of the fungi that can produce the secondary metabolites,
including antimicrobial agents, industrial and biotechnological products. Methodology: A. niger was tested against
Candida albicans on the same petri dish of potato dextrose agar at room temperature. A. niger was cultured in potato
dextrose broth at 27 °C for 7 days. The fungal filtrate was separated from mycelia, and the filtrate was extracted for
getting a crude blackish-brown extract. The GC-MS analysis used to identify the constituents of the extract. Results:
The filtrate crude extract of A. niger exhibited the antimicrobial effects against Staphylococcus aureus, Streptococcus
mutans, Escherichia coli, and Candida albicans.GC-MS analysis revealed that the extract contains [(5-methyl-2-
phenylindolizine), (thiocarbamic acid, N,N-dimethyl, S-1,3-diphenyl-2-butenyl ester) and (22-beta.-acetoxy3.beta.,16.alpha.-dihydroxy-13,28epoxyolean-2)].The extract had the toxic effect on a solution of the human red blood
cells by using 300 µL of 10 mg/ml after 5 minutes while 100 µL and 200 µL of the same concentration did not appear
the toxic effects during 1 hour of the testing time period. Conclusions: The extract of A. niger has the ability to produce
the antimicrobial activity, so it very needs to separate its constituents into pure compounds for elucidating their
chemical structure by using techniques of spectrometry. Then, the compounds can be separately testing against
microbial pathogens, human normal cell to determine half lethal concentration (LC50)), and application of other
biological tests such as test of LD50. Finally, the identified and purified compounds will be tested by volunteers in order
to identify the side effects and toxicity of these compounds to be implemented as drugs for treating diseases in the
hospitals |
---|---|
ISSN: | 1991-8690 2709-0256 |
DOI: | 10.32792/utq/utjsci/v7i1.253 |